Dynamics in Post-pandemic Global Pemetrexed Drug Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668695
Publisher: Date of Publish:
No. of Pages: 138 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pemetrexed Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pemetrexed Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category 100 mg lyophilized powder/vial 500 mg lyophilized powder/vial Segmented by End User/Segment Pleural mesothelioma Non-small cell lung cancer Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Teva Qilu Pharmaceutical Pfizer Eli Lilly and Company Eagle Pharmaceuticals Biocon APOTEX
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Pemetrexed Drug Market Status and Forecast (2016-2027) 1.3.2 Global Pemetrexed Drug Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Pemetrexed Drug Supply by Company 2.1 Global Pemetrexed Drug Sales Volume by Company 2.2 Global Pemetrexed Drug Sales Value by Company 2.3 Global Pemetrexed Drug Price by Company 2.4 Pemetrexed Drug Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Pemetrexed Drug Market Status by Category 3.1 Pemetrexed Drug Category Introduction 3.1.1 100 mg lyophilized powder/vial 3.1.2 500 mg lyophilized powder/vial 3.2 Global Pemetrexed Drug Market by Category 3.2.1 Global Pemetrexed Drug Sales Volume by Category (2016-2021) 3.2.2 Global Pemetrexed Drug Sales Value by Category (2016-2021) 3.2.3 Global Pemetrexed Drug Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Pemetrexed Drug Market Status by End User/Segment 4.1 Pemetrexed Drug Segment by End User/Segment 4.1.1 Pleural mesothelioma 4.1.2 Non-small cell lung cancer 4.2 Global Pemetrexed Drug Market by End User/Segment 4.2.1 Global Pemetrexed Drug Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Pemetrexed Drug Sales Value by End User/Segment (2016-2021) 4.2.3 Global Pemetrexed Drug Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Pemetrexed Drug Market Status by Region 5.1 Global Pemetrexed Drug Market by Region 5.1.1 Global Pemetrexed Drug Sales Volume by Region 5.1.2 Global Pemetrexed Drug Sales Value by Region 5.2 North America Pemetrexed Drug Market Status 5.3 Europe Pemetrexed Drug Market Status 5.4 Asia Pacific Pemetrexed Drug Market Status 5.5 Central & South America Pemetrexed Drug Market Status 5.6 Middle East & Africa Pemetrexed Drug Market Status 6 North America Pemetrexed Drug Market Status 6.1 North America Pemetrexed Drug Market by Country 6.1.1 North America Pemetrexed Drug Sales Volume by Country (2016-2021) 6.1.2 North America Pemetrexed Drug Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Pemetrexed Drug Market Status 7.1 Europe Pemetrexed Drug Market by Country 7.1.1 Europe Pemetrexed Drug Sales Volume by Country (2016-2021) 7.1.2 Europe Pemetrexed Drug Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Pemetrexed Drug Market Status 8.1 Asia Pacific Pemetrexed Drug Market by Country 8.1.1 Asia Pacific Pemetrexed Drug Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Pemetrexed Drug Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Pemetrexed Drug Market Status 9.1 Central & South America Pemetrexed Drug Market by Country 9.1.1 Central & South America Pemetrexed Drug Sales Volume by Country (2016-2021) 9.1.2 Central & South America Pemetrexed Drug Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Pemetrexed Drug Market Status 10.1 Middle East & Africa Pemetrexed Drug Market by Country 10.1.1 Middle East & Africa Pemetrexed Drug Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Pemetrexed Drug Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Pemetrexed Drug Manufacturing Cost Analysis 11.5 Pemetrexed Drug Sales Channel and Distributors Analysis 11.5.1 Pemetrexed Drug Sales Channel 11.5.2 Pemetrexed Drug Distributors 11.6 Pemetrexed Drug Downstream Major Buyers 12 Global Pemetrexed Drug Market Forecast by Category and by End User/Segment 12.1 Global Pemetrexed Drug Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Pemetrexed Drug Forecast by Category 12.2.1 Global Pemetrexed Drug Sales Volume Forecast by Category 12.2.2 Global Pemetrexed Drug Sales Value Forecast by Category 12.2.3 Global Pemetrexed Drug Price Forecast by Category 12.3 Global Pemetrexed Drug Forecast by End User/Segment 12.3.1 Global Pemetrexed Drug Sales Volume Forecast by End User/Segment 12.3.2 Global Pemetrexed Drug Sales Value Forecast by End User/Segment 12.3.3 Global Pemetrexed Drug Price Forecast by End User/Segment 13 Global Pemetrexed Drug Market Forecast by Region/Country 13.1 Global Pemetrexed Drug Market Forecast by Region (2022-2027) 13.1.1 Global Pemetrexed Drug Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Pemetrexed Drug Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Teva 14.1.1 Company Information 14.1.2 Pemetrexed Drug Product Introduction 14.1.3 Teva Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Qilu Pharmaceutical 14.2.1 Company Information 14.2.2 Pemetrexed Drug Product Introduction 14.2.3 Qilu Pharmaceutical Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Pfizer 14.3.1 Company Information 14.3.2 Pemetrexed Drug Product Introduction 14.3.3 Pfizer Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Eli Lilly and Company 14.4.1 Company Information 14.4.2 Pemetrexed Drug Product Introduction 14.4.3 Eli Lilly and Company Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Eagle Pharmaceuticals 14.5.1 Company Information 14.5.2 Pemetrexed Drug Product Introduction 14.5.3 Eagle Pharmaceuticals Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Biocon 14.6.1 Company Information 14.6.2 Pemetrexed Drug Product Introduction 14.6.3 Biocon Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 APOTEX 14.7.1 Company Information 14.7.2 Pemetrexed Drug Product Introduction 14.7.3 APOTEX Pemetrexed Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis ... 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com